Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Sexually Transmitted Diseases
Basic InformationLatest News
Repeat Infection Likely for Men With HPVNivolumab May Induce Successful Depletion of HIV ReservoirHIV Is Gaining Resistance to Lifesaving DrugsLung Cancer Drug Targets 'Hidden' HIV in French PatientIncidence of HIV Dropped From 1999 to 2016 in UgandaHIV Diagnoses Occurring More Quickly, CDC SaysPot May Alter Brain Function of Some With HIVAlmost 21 Million Worldwide Now Have Access to HIV MedsPoorer Neuropsychological Test Scores for HIV-PositiveOhio Upholds Law Requiring HIV-Infected to Tell Sex PartnersHIV Drug Resistance Is Threatening Gains of TreatmentAre HIV and AIDS Poised for a Comeback?HPV Vaccine Safe for Adult Women: Study1 in 9 American Men Infected With Oral HPVWorse HIV Care Outcomes for Hispanics, LatinosSizable Number of HIV-Infected Children Not Receiving CareHundreds Hospitalized in San Diego as Hepatitis A Outbreak SpreadsHigh Coffee Intake Tied to Lower Mortality in HIV/HCVVaginal Bacteria Tied to Heightened Chlamydia RiskCDC: STDs Peak in 2016, Exceeding 2 Million CasesNotification Rates of New HIV Diagnoses Up in Older AdultsSTDs Hit All-Time High in U.S.Combination Strategy Could Be Key in HIV PreventionFighting HIV on Multiple Fronts Might Lead to VaccineExpected Burden of Lung Cancer High for People Living With HIVHIV and Smoking a Lethal Combo for the LungsIn HIV, Tissue Factor-Expressing Monocytes Trigger CoagulationDrug Helped Protect Gay Teen Males From HIVInsurer Aetna's Envelopes Revealed Customers' HIV StatusMore U.S. Teens Getting Vaccinated Against HPVRebound Seen Predelivery After HIV Suppression in PregnancyOnly About One-Third of Americans Use Condoms: CDCSingle Measures of Viral Load May Overestimate HIV SuppressionFDA Approves Mavyret for Hepatitis CHIV Treatment Protects Uninfected Partner From the VirusBacteria May Explain Why Uncircumcised Face Higher HIV RiskLong-Acting Antiretroviral Injection Safe, Effective for HIVMeds by Monthly Injection Might Revolutionize HIV CareCows May Offer Clues to an AIDS VaccineEHR-Based Prompt Ups Hepatitis C Screening for Baby BoomersWider Access to Meds Cuts Global AIDS Deaths in HalfRare Skin Manifestations Can Indicate Secondary SyphilisNew Hope in Search for Vaccine Against GonorrheaIn HIV, Greater BMD Decline for Immediate Versus Delayed ARTHIV Testing Inadequate in Young Men Who Have Sex With MenFinancial Incentives May Increase Viral Suppression in HIVHigh HCV Cure Rates in HIV Coinfection Cases at Urban ClinicAdding in Prescription for Partner Boosts STD CareReduced Corneal Nerve Fiber Density in Patients With HIVFDA Approves Generic Version of HIV Drug Truvada
Questions and AnswersLinksBook Reviews
Related Topics

Homosexuality & Bisexuality
Relationship Problems

Is the AIDS Epidemic Winding Down in the U.S.?

HealthDay News
by -- Robert Preidt
Updated: May 17th 2017

new article illustration

WEDNESDAY, May 17, 2017 (HealthDay News) -- Could the United States be turning the corner on the AIDS epidemic?

New research suggests it's possible.

If certain targets are met, the rate of new infections may be down to 12,000 a year by 2025, which would mark a transition toward the end of the HIV/AIDS epidemic, the researchers said.

"Achieving these targets will require a sustained and intensified national commitment to ending the epidemic," said study author Dr. Robert Bonacci, from Brigham and Women's Hospital in Boston.

"But if the U.S. does achieve a reduction to 12,000 new HIV infections by 2025, it could mark an important turning point in the U.S. HIV epidemic: a decline in the total number of people living with HIV in the U.S., and the beginning of the end of the U.S. AIDS epidemic," he said in a hospital news release.

It's crucial that the goals of the U.S. National HIV/AIDS Strategy (NHAS) are met. The goals for 2020 include: 90 percent of people living with HIV knowing their status; 90 percent receiving quality care; and 90 percent of HIV patients on antiretroviral therapy achieving suppression of the virus.

Rates of 95 percent would have to be achieved by 2025, the researchers said.

It's especially important that these targets are reached among groups hardest hit by HIV, including gay men, young people, transgender persons, black and Hispanic Americans and those who live in southern states.

"Providing HIV services to our most disproportionately affected communities is fundamental to future success," said study senior author David Holtgrave, from Johns Hopkins Bloomberg School of Public Health.

"In an era of limited funding and competing priorities, it is critically important that we intensify our national commitment to addressing the HIV epidemic over the next decade," he added.

The research was published online May 15 in the American Journal of Preventive Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more on HIV/AIDS.